Innovation has been stagnant in beauty and wellness for decades.
Across hair, skin, and body wellness, genuine innovation and discovery has been avoided in favor of less challenging programs to retest and reformulate legacy ingredients.
We leverage our molecular discovery pipeline to drive molecule and biological modality development for the most pressing visible (and invisible) challenges of wellness.
To achieve our mission, we use the same cutting-edge bioengineering and advanced AI techniques used to develop new medicines and cancer therapeutics and apply them to discover new molecules that directly target the issues impacting millions of people every day.
It's 2024. We have supercomputers in our pockets and technologies to edit entire genomes, yet consumers are still forced to accept the same ingredients their grandparents had, and continue to experience the same underwhelming results.
The products using our breakthrough molecules demonstrate safe and superior clinical efficacy as compared to what's currently on the market. Rather than rebranding what is already available, we reinvent what just isn't cutting it for consumers.
We explore the universe of existing and potential molecules with our multi-layered technology platform
.gif)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.jpeg)
“With the acquisition of Boston-based Revela, a leading biotech startup, and the establishment of ODDITY LABS, the company is at the vanguard, bringing a proven drug discovery technology into beauty and wellness.”
Continue reading.
Beauty consumers are constantly searching for products that deliver on their marketing promises. But for all the advances beauty innovation is capable of from a formulation perspective, there are some limits to what is possible by cosmetic chemists in a lab.
Keep reading.
Beauty consumers are constantly searching for products that deliver on their marketing promises. But for all the advances beauty innovation is capable of from a formulation perspective, there are some limits to what is possible by cosmetic chemists in a lab.
Keep reading.
"Each of the startups selected for the Boston cohort is unique and disruptive. From quantum to AI to nano, these startups are building and innovating for the future, and they are pushing the envelope of what it means to create impact in deep tech."
Keep reading.
-cropped%20(1).svg){kind=avatar}
Who would even know where to begin finding the next "notable contender" in the antiaging skin-care space? In the case of the latest ingredient, Fibroquin, it turns out that the answer is downright robotic (wink, wink)
Continue reading.
